Letrozole is an active drug ingredient that’s available as a generic medication. It comes as oral tablets that you’ll swallow. Letrozole is a hormone therapy for breast cancer. Read on to ...

APP will market Letrozole in 2.5 mg tablets. According to IMS data, sales of the branded product in the United States were approximately $619.4 million, with approximately 1,775,000 bottles of 30 ...

These kinases are activated upon binding to D-cyclins and play a crucial role in signaling pathways which lead to cell cycle progression and cellular proliferation. The Food and Drug ...

Letrozole Tablets are the generic version of Novartis' Femara® Tablets, an adjuvant treatment for postmenopausal women with hormone receptor-positive early stage breast cancer.

announced today that Chugai and Novartis Pharma K.K. have agreed to terminate the agreement regarding co-marketing of aromatase inhibitor "Femara® tablets 2.5 mg" (generic name: letrozole ...

Bicalutamide tablets are oral non-steroidal anti-androgen used in the treatment of prostate cancer. The drugmaker also received a tentative U.S. FDA approval for letrozole tablets used in the ...

Ranbaxy Laboratories Ltd on Monday announced the launch of Letrozole tablets 2.5 mg in the UK, Romania and France, on Day-1. Letrozole is an Antineoplastics, indicated for the treatment of breast ...

The aromatase inhibitor letrozole, by suppressing estrogen production, might improve the outcome after the discontinuation of tamoxifen therapy. A total of 5187 women were enrolled (median follow ...